Biktarvy, formally known as biktarvy, is a potent single-tablet regimen for managing HIV infection. This drug combines three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by inhibiting the HIV's ability to multiply within the body, significantly reducing the viral quantity. For many individuals,